Neuronetics, Inc. (STIM) — Stock Score Summary

Neuronetics, Inc. (STIM) has a MoatMap StockRank of 13/100 based on Quality (31/100), Value (40/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL. Neuronetics manufactures TMS systems but suffers from low margins, high sales friction, and a lack of clear competitive advantages in the neurotech space.

Neuronetics, Inc. is a medical device company that develops and markets the NeuroStar Advanced Therapy system, a non-invasive transcranial magnetic stimulation (TMS) treatment for major depressive disorder (MDD). The company holds a leading position in the TMS market, benefiting from FDA clearance and clinical validation for its technology. Neuronetics provides an important drug-free alternative for patients who have not achieved satisfactory results with antidepressant medications.

Key Financial Metrics

Price$1.24
Market Cap$107M
P/E (Forward)-4.34
Price/Book7.64
Return on Equity-131.6%
Return on Invested Capital-28.4%
Debt/Equity500.52
Gross Margin48.2%
Operating Margin-26.1%
Revenue Growth7.8%
Free Cash Flow$-5M

Neuronetics, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Neuronetics, Inc.’s (STIM) StockRank?
MoatMap’s StockRank for Neuronetics, Inc. (STIM) is 13/100, with a Strong Sell signal. It is a composite of Quality (31), Value (40), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does Neuronetics, Inc. have an economic moat?
Neuronetics, Inc. (STIM) has a Quality factor score of 31/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Neuronetics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Neuronetics, Inc. (STIM) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Neuronetics, Inc. in?
Neuronetics, Inc. (STIM) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksSTIM deep dive reportAI ChampionsHow we score stocksSense-check another stock